Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Reuter

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Seminars in Urology|August 1, 1990
Neoadjuvant chemotherapy for bladder cancer: the MSKCC experienceW R Fair, H Scher, H Herr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasmsH I Scher, A Sarkis, V Reuter, et al.
The Journal of Urology|May 1, 1995
TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49P C Brenner, W J Rettig, M P Sanz-Moncasi, et al.
British Journal of Cancer|November 2, 2006
Long-term outcome among men with conservatively treated localised prostate cancerJ Cuzick, G Fisher, M W Kattan, et al.
Genes, Chromosomes & Cancer|March 1, 1990
Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplificationF Samaniego, E Rodriguez, J Houldsworth, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletionL D Nord, R L Stolfi, A A Alfieri, et al.
Molecular Urology|November 4, 2000
Three-dimensional ultrasound analyses of the prostateE J Feleppa, W R Fair, T Liu, et al.
Cancer Research|October 15, 1992
Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expressionR J Motzer, D M Nanus, P O'Moore, et al.
The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesionH I Scher, A Yagoda, H W Herr, et al.
The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumorsH I Scher, A Yagoda, H W Herr, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Seminars in Urology|August 1, 1990
Neoadjuvant chemotherapy for bladder cancer: the MSKCC experienceW R Fair, H Scher, H Herr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasmsH I Scher, A Sarkis, V Reuter, et al.
The Journal of Urology|May 1, 1995
TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49P C Brenner, W J Rettig, M P Sanz-Moncasi, et al.
British Journal of Cancer|November 2, 2006
Long-term outcome among men with conservatively treated localised prostate cancerJ Cuzick, G Fisher, M W Kattan, et al.
Genes, Chromosomes & Cancer|March 1, 1990
Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplificationF Samaniego, E Rodriguez, J Houldsworth, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletionL D Nord, R L Stolfi, A A Alfieri, et al.
Molecular Urology|November 4, 2000
Three-dimensional ultrasound analyses of the prostateE J Feleppa, W R Fair, T Liu, et al.
Cancer Research|October 15, 1992
Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expressionR J Motzer, D M Nanus, P O'Moore, et al.
The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesionH I Scher, A Yagoda, H W Herr, et al.
The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumorsH I Scher, A Yagoda, H W Herr, et al.
Pageof 6